Eton Pharmaceuticals to Report First Quarter 2021 Financial Results on Thursday, May 13, 2021

Rhea-AI Summary

Eton Pharmaceuticals (Nasdaq: ETON) will release its first quarter 2021 financial and operating results on May 13, 2021. A conference call and audio webcast to discuss these results will be held at 4:30 p.m. ET. Investors can access the live webcast on the company’s investor relations website and listen by dialing specific numbers for domestic and international calls. Eton develops treatments for rare diseases and owns or earns royalties from three FDA-approved products while advancing six additional products submitted to the FDA.

Positive

• Eton owns or receives royalties from three FDA-approved products.
• Six additional products have been submitted to the FDA.

Negative

• None.

DEER PARK, Ill., May 04, 2021 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that it will report first quarter 2021 financial and operating results on Thursday, May 13, 2021. Management will host a conference call and live audio webcast to discuss these results and provide a business update at 4:30 p.m. ET (3:30 p.m. CT).

The live webcast can be accessed on the investors section of Eton’s website at https://ir.etonpharma.com/. The conference call can be accessed by dialing 1-866-795-8473 (domestic) or 1-470-495-9161 (international) and refer to conference ID 5847989. An archived webcast will be available on Eton’s website approximately two hours after the completion of the event and for 30 days thereafter.

About Eton Pharmaceuticals
Eton Pharmaceuticals, Inc. is an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases. The company currently owns or receives royalties from three FDA-approved products, including ALKINDI^® SPRINKLE, Biorphen^®, and Alaway^® Preservative Free, and has six additional products that have been submitted to the FDA.

Investor Contact:
David Krempa
dkrempa@etonpharma.com
612-387-3740

FAQ

When will Eton Pharmaceuticals report its first quarter 2021 results?

Eton Pharmaceuticals will report its first quarter 2021 results on May 13, 2021.

What time is the Eton Pharmaceuticals conference call?

The conference call for Eton Pharmaceuticals will be held at 4:30 p.m. ET on May 13, 2021.

How can I access the Eton Pharmaceuticals webcast?

You can access the Eton Pharmaceuticals webcast on the investors section of their website.

What products does Eton Pharmaceuticals have on the market?

Eton Pharmaceuticals has three FDA-approved products: ALKINDI® SPRINKLE, Biorphen®, and Alaway® Preservative Free.

How many products has Eton Pharmaceuticals submitted to the FDA?

Eton Pharmaceuticals has submitted six additional products to the FDA.